Systemic anticancer therapy in the last 30 days of life: Retrospective audit from an Australian Regional Cancer Centre

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Peter J GilbarSrinivas Kondalsamy-Chennakes

Abstract

Cessation of chemotherapy at an appropriate time is an important component of good quality palliative care. Published studies looking at administration of chemotherapy at the end of life vary widely. To retrospectively determine the rate of death occurring within 14 and 30 days of chemotherapy and use this to benchmark against other cancer centres as a quality of care measure. All adult patients who received systemic anticancer therapy for solid tumours and haematological malignancies at an Australian Regional Cancer Centre between 2011 and 2015 were included. Over a five-year period, 1215 patients received systemic anticancer therapy. Of these, 23 (1.89%) died within 14 days following systemic anticancer therapy and 68 (5.60%) within 30 days. All patients who died had been treated with palliative intent. Mean time to death was 17.7 days. The majority were female (61.8%) and the mean age was 62.3 years. The most common cause of death was disease progression (80.9%). Nearly half died at the Regional Cancer Centre, including 30.9% who lived in rural or remote localities. The rate of death observed in this study is at the lower end of the range seen in published studies for both the last 14 and 30 days post-systemic anticancer the...Continue Reading

References

Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleSusan Block
Apr 16, 2003·Annals of Internal Medicine·Ezekiel J EmanuelArlene S Ash
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Jun 30, 2005·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Craig C EarleJohn Z Ayanian
Jul 12, 2005·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Hester KlopperBjörn Sjöström
Aug 23, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·José Ferraz Gonçalves, Carmen Goyanes
Apr 16, 2008·Japanese Journal of Clinical Oncology·Bhumsuk KeamDae Seog Heo
Jun 12, 2008·JAMA : the Journal of the American Medical Association·Sarah Elizabeth Harrington, Thomas J Smith
May 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KaoD Adams
Mar 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U NäppäB Axelsson
Sep 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Braga
Dec 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A GreerJennifer S Temel
Jul 17, 2012·Journal of Palliative Medicine·Thomas I Peng SohAlvin Seng Cheong Wong
Aug 18, 2012·Asia-Pacific Journal of Clinical Oncology·Jaclyn YoongGeoffrey Chong
Dec 19, 2012·Nature Reviews. Clinical Oncology·Gabrielle B Rocque, James F Cleary
Dec 17, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L KhojaJ Hasan
Apr 23, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paola PacettiMaurizio Cantore
Jul 24, 2015·JAMA Oncology·Holly G PrigersonPaul K Maciejewski
Sep 24, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Tarek AssiJoseph Kattan
Nov 26, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wing-lok ChanKwok-keung Yuen

❮ Previous
Next ❯

Citations

Oct 18, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Estela García-MartínMiguel Martín
May 16, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Bernadatte ZimbwaSrinivas Kondalsamy-Chennakesavan

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.